WASHINGTON — The FDA abruptly reversed course this week on its efforts to ban Juul e-cigarette gross sales, an embarrassing about-face that calls into query the reasoning behind the company’s preliminary choice, consultants stated.
Tuesday night, the Meals and Drug Administration introduced it was giving Juul’s software for its vaping merchandise a re-examination due to “scientific points … that warrant further assessment.” The transfer got here lower than two weeks after the FDA made worldwide headlines for ordering the entire vaping large’s merchandise off the market, prompting reward from lawmakers and advocates alike.
